Ind Swift Laboratories
100.49
-0.95(-0.94%)
Market Cap₹614.90 Cr
PE Ratio34.17
IndustryHealthcare
Company Performance:
1D-0.94%
1M-6.00%
6M+10.72%
1Y-22.78%
5Y+163.41%
View Company Insightsright
Latest news about Ind Swift Laboratories
Ind-Swift Lab Reports Q1 EBITDA Turnaround, Revenue Growth Amid Profit Decline 5 days ago
Ind Swift Laboratories Limited reported mixed Q1 financial results. The company achieved an EBITDA turnaround, posting ₹36.00 million compared to a ₹65.00 million loss in the previous year, with an EBITDA margin of 2.36%. Revenue grew by 4.08% to ₹1.53 billion. However, consolidated net profit declined by 69.86% to ₹88.00 million from ₹292.00 million in the same quarter last year. The board approved these unaudited results in a meeting on August 13.
Ind Swift Laboratories Reports Strong Profit Growth and Completes Merger with Ind Swift Limited 7 days ago
Ind-Swift Laboratories Merger with Ind-Swift Limited Gets NCLT Approval, Effective August 8, 2025 Jul 31, 2025
Ind-Swift Laboratories Secures NCLT Approval for Merger with Ind-Swift Limited Jul 28, 2025
Ind-Swift Laboratories Invests ₹950 Million in Khandelwal Finance's OCRPS Jun 18, 2025
More news about Ind Swift Laboratories
28Mar 25
Ind-Swift Laboratories Approves Rs 20 Crore Short-Term Advance to Ashok Investors Trust
Ind-Swift Laboratories Ltd (ISLL) has approved a short-term advance of up to Rs 20 crore to Ashok Investors Trust Limited (AITL), a registered NBFC. The advance is in the form of an Inter-Corporate Deposit with a 30-day term, extendable for another 30 days, at 10% annual interest. The transaction is secured by post-dated cheques and is not a related party transaction. ISLL already holds 800 NCDs of AITL, each with a face value of Rs 5,00,000.
Ind Swift Laboratories
100.49
-0.95
(-0.94%)
1 Year Returns:-22.78%
Industry Peers
Sun Pharmaceutical
1,632.70
(-0.53%)
Divis Laboratories
6,164.50
(+0.52%)
Cipla
1,565.20
(+0.08%)
Torrent Pharmaceuticals
3,651.60
(+0.79%)
Dr Reddys Laboratories
1,262.70
(+0.18%)
Mankind Pharma
2,472.40
(-0.01%)
Zydus Life Science
986.50
(-0.23%)
Lupin
1,968.30
(+0.34%)
Abbott
32,590.00
(-2.03%)
Alkem Laboratories
5,346.00
(-0.03%)